Terapia innovativa: oltre il PEB? Relatore: Dr ... - Oncologia Rimini
Terapia innovativa: oltre il PEB? Relatore: Dr ... - Oncologia Rimini
Terapia innovativa: oltre il PEB? Relatore: Dr ... - Oncologia Rimini
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Prognostic factors in relapsed or refractory germ-cell tumors<br />
ASCO 2009 - Abstr # 5030<br />
A. Lorch, J. Beyer , C. Mollevi, M. Guerra, A. Kramar for the International Group on<br />
Prognostic Factors in Relapsed or Refractory Germ-Cell Tumors<br />
Prognostic model<br />
Variable<br />
Points<br />
0<br />
1<br />
2<br />
3<br />
Primary site<br />
Gonadal<br />
Retroperitoneal<br />
Mediastinal<br />
Response first-line<br />
CR/PRm-<br />
PRm+/SD<br />
PD<br />
PFI<br />
> 3 months<br />
≤ 3 months<br />
AFP at salvage<br />
Normal<br />
Change language